Published in Magn Reson Med on November 14, 2011
Nuts and bolts of chemical exchange saturation transfer MRI. NMR Biomed (2013) 1.88
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
MR imaging of the amide-proton transfer effect and the pH-insensitive nuclear overhauser effect at 9.4 T. Magn Reson Med (2012) 1.67
CEST: from basic principles to applications, challenges and opportunities. J Magn Reson (2012) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed (2013) 1.23
Quantitative tissue pH measurement during cerebral ischemia using amine and amide concentration-independent detection (AACID) with MRI. J Cereb Blood Flow Metab (2014) 1.15
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression. J Am Chem Soc (2013) 1.15
Inverse Z-spectrum analysis for spillover-, MT-, and T1 -corrected steady-state pulsed CEST-MRI--application to pH-weighted MRI of acute stroke. NMR Biomed (2014) 1.11
Chemical Exchange Saturation Transfer (CEST) Imaging: Description of Technique and Potential Clinical Applications. Curr Radiol Rep (2013) 1.08
MRI biosensor for protein kinase A encoded by a single synthetic gene. Magn Reson Med (2012) 1.07
CEST signal at 2ppm (CEST@2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed (2014) 1.06
Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients. NMR Biomed (2014) 1.05
Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla. Magn Reson Med (2015) 1.03
Quantitative characterization of nuclear overhauser enhancement and amide proton transfer effects in the human brain at 7 tesla. Magn Reson Med (2012) 1.02
Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI. Magn Reson Med (2013) 1.01
Contributors to contrast between glioma and brain tissue in chemical exchange saturation transfer sensitive imaging at 3 Tesla. Neuroimage (2014) 0.98
Three-dimensional turbo-spin-echo amide proton transfer MR imaging at 3-Tesla and its application to high-grade human brain tumors. Mol Imaging Biol (2013) 0.95
Amide proton transfer imaging of the human breast at 7T: development and reproducibility. NMR Biomed (2013) 0.94
Imaging amide proton transfer and nuclear overhauser enhancement using chemical exchange rotation transfer (CERT). Magn Reson Med (2013) 0.94
A diaCEST MRI approach for monitoring liposomal accumulation in tumors. J Control Release (2014) 0.91
Evaluation of the dependence of CEST-EPI measurement on repetition time, RF irradiation duty cycle and imaging flip angle for enhanced pH sensitivity. Phys Med Biol (2013) 0.91
Quantitative chemical exchange saturation transfer (qCEST) MRI--RF spillover effect-corrected omega plot for simultaneous determination of labile proton fraction ratio and exchange rate. Contrast Media Mol Imaging (2014) 0.90
Highly accelerated chemical exchange saturation transfer (CEST) measurements with linear algebraic modeling. Magn Reson Med (2015) 0.89
Chemical exchange saturation transfer (CEST) imaging with fast variably-accelerated sensitivity encoding (vSENSE). Magn Reson Med (2016) 0.89
Advantages of chemical exchange-sensitive spin-lock (CESL) over chemical exchange saturation transfer (CEST) for hydroxyl- and amine-water proton exchange studies. NMR Biomed (2014) 0.87
Evaluating the use of a continuous approximation for model-based quantification of pulsed chemical exchange saturation transfer (CEST). J Magn Reson (2012) 0.87
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy. Breast Cancer (Dove Med Press) (2012) 0.87
Sensitivity-enhanced chemical exchange saturation transfer (CEST) MRI with least squares optimization of Carr Purcell Meiboom Gill multi-echo echo planar imaging. Contrast Media Mol Imaging (2014) 0.86
Application of chemical exchange saturation transfer (CEST) MRI for endogenous contrast at 7 Tesla. J Neuroimaging (2013) 0.86
Selecting the reference image for registration of CEST series. J Magn Reson Imaging (2015) 0.85
Imaging of endogenous exchangeable proton signals in the human brain using frequency labeled exchange transfer imaging. Magn Reson Med (2013) 0.84
Multi-echo length and offset VARied saturation (MeLOVARS) method for improved CEST imaging. Magn Reson Med (2014) 0.84
Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed (2014) 0.83
Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T. Magn Reson Med (2015) 0.82
A review of optimization and quantification techniques for chemical exchange saturation transfer MRI toward sensitive in vivo imaging. Contrast Media Mol Imaging (2015) 0.81
Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.81
Time domain removal of irrelevant magnetization in chemical exchange saturation transfer Z-spectra. Magn Reson Med (2013) 0.80
Design and optimization of pulsed Chemical Exchange Saturation Transfer MRI using a multiobjective genetic algorithm. J Magn Reson (2015) 0.79
Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T. J Magn Reson Imaging (2015) 0.79
On-resonance variable delay multipulse scheme for imaging of fast-exchanging protons and semisolid macromolecules. Magn Reson Med (2016) 0.78
In vivo imaging of paraCEST agents using frequency labeled exchange transfer MRI. Magn Reson Med (2013) 0.77
Magnetization transfer prepared gradient echo MRI for CEST imaging. PLoS One (2014) 0.77
Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue. Radiology (2014) 0.77
Transfer Rate Edited experiment for the selective detection of Chemical Exchange via Saturation Transfer (TRE-CEST). J Magn Reson (2015) 0.76
A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI. Contrast Media Mol Imaging (2015) 0.76
Molecular Imaging Using Endogenous Cellular Proteins. Bo Pu Xue Za Zhi (2013) 0.75
Amide proton transfer magnetic resonance imaging of Alzheimer's disease at 3.0 Tesla: a preliminary study. Chin Med J (Engl) (2015) 0.75
Chemical exchange saturation transfer of the cervical spinal cord at 7 T. NMR Biomed (2016) 0.75
MR Imaging Biomarkers in Oncology Clinical Trials. Magn Reson Imaging Clin N Am (2016) 0.75
Insight into the quantitative metrics of chemical exchange saturation transfer (CEST) imaging. Magn Reson Med (2016) 0.75
Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI. Sci Rep (2017) 0.75
A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson (2000) 8.73
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med (2005) 6.17
Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn Reson Med (2005) 4.75
Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med (1989) 4.68
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Assessment of glycosaminoglycan concentration in vivo by chemical exchange-dependent saturation transfer (gagCEST). Proc Natl Acad Sci U S A (2008) 4.43
Magnetization transfer in MRI: a review. NMR Biomed (2001) 4.38
Chemical exchange saturation transfer (CEST): what is in a name and what isn't? Magn Reson Med (2011) 4.08
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu Rev Biomed Eng (2008) 3.53
Determination of pH using water protons and chemical exchange dependent saturation transfer (CEST). Magn Reson Med (2000) 3.46
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med (2006) 2.87
Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med (2004) 2.80
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
The dynamics of water-protein interactions. Annu Rev Biophys Biomol Struct (1996) 2.59
Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med (2001) 2.22
Detection of proton chemical exchange between metabolites and water in biological tissues. J Magn Reson (1998) 2.19
Accurate quantitation of water-amide proton exchange rates using the phase-modulated CLEAN chemical EXchange (CLEANEX-PM) approach with a Fast-HSQC (FHSQC) detection scheme. J Biomol NMR (1998) 2.14
Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med (2003) 2.14
Perfusion imaging with compensation for asymmetric magnetization transfer effects. Magn Reson Med (1996) 2.03
Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med (2007) 1.88
Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Acc Chem Res (2009) 1.86
Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents. Magn Reson Med (2008) 1.85
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
PARACEST MRI with improved temporal resolution. Magn Reson Med (2009) 1.69
Magnetization transfer phenomenon in the human brain at 7 T. Neuroimage (2009) 1.67
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
CEST-FISP: a novel technique for rapid chemical exchange saturation transfer MRI at 7 T. Magn Reson Med (2010) 1.50
Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med (1998) 1.43
Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke. Magn Reson Med (2008) 1.39
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magn Reson Med (2006) 1.34
Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imaging (2010) 1.31
A multislice gradient echo pulse sequence for CEST imaging. Magn Reson Med (2010) 1.29
Development of chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.26
The general solution to the Bloch equation with constant rf and relaxation terms: application to saturation and slice selection. Med Phys (1993) 1.21
Suppression of lipid artifacts in amide proton transfer imaging. Magn Reson Med (2005) 1.19
New high dielectric constant materials for tailoring the B1+ distribution at high magnetic fields. J Magn Reson (2010) 1.17
Direct saturation MRI: theory and application to imaging brain iron. Magn Reson Med (2009) 0.88
Mapping brain metabolites using a double echo-filter metabolite imaging (DEFMI) technique. J Magn Reson (1999) 0.86
Contributions from hydration of carboxylate groups to the spectrum of water-polypeptide proton-proton Overhauser effects in aqueous solution. J Biomol NMR (1993) 0.78
Fiber tract-based atlas of human white matter anatomy. Radiology (2003) 10.18
Fiber tracking: principles and strategies - a technical review. NMR Biomed (2002) 8.52
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med (2003) 6.57
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med (2003) 4.57
Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med (2004) 4.25
Artificial reporter gene providing MRI contrast based on proton exchange. Nat Biotechnol (2007) 3.87
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67
Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med (2010) 3.62
Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med (2009) 3.57
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood. Neuroimage (2005) 3.11
Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magn Reson Med (2008) 2.93
Amide proton transfer imaging of human brain tumors at 3T. Magn Reson Med (2006) 2.87
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Detection of the ischemic penumbra using pH-weighted MRI. J Cereb Blood Flow Metab (2006) 2.77
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Spatial normalization of diffusion tensor fields. Magn Reson Med (2003) 2.70
White and gray matter development in human fetal, newborn and pediatric brains. Neuroimage (2006) 2.55
New "multicolor" polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI. Magn Reson Med (2008) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Multi-contrast human neonatal brain atlas: application to normal neonate development analysis. Neuroimage (2011) 2.41
Analysis of noise effects on DTI-based tractography using the brute-force and multi-ROI approach. Magn Reson Med (2004) 2.35
Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med (2007) 2.22
Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage (2010) 2.21
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Mechanism of magnetization transfer during on-resonance water saturation. A new approach to detect mobile proteins, peptides, and lipids. Magn Reson Med (2003) 2.14
DTI tractography based parcellation of white matter: application to the mid-sagittal morphology of corpus callosum. Neuroimage (2005) 2.13
Optimization of the irradiation power in chemical exchange dependent saturation transfer experiments. J Magn Reson (2005) 2.11
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging. Neuroimage (2009) 2.01
Routine clinical brain MRI sequences for use at 3.0 Tesla. J Magn Reson Imaging (2005) 1.94
Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med (2006) 1.94
Atlas-based analysis of neurodevelopment from infancy to adulthood using diffusion tensor imaging and applications for automated abnormality detection. Neuroimage (2010) 1.89
A framework for callosal fiber distribution analysis. Neuroimage (2002) 1.87
Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med (2012) 1.84
Simplified quantitative description of amide proton transfer (APT) imaging during acute ischemia. Magn Reson Med (2007) 1.83
Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage (2003) 1.80
MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast. Neuroimage (2010) 1.74
Amide proton transfer MR imaging of prostate cancer: a preliminary study. J Magn Reson Imaging (2011) 1.73
Developing MR reporter genes: promises and pitfalls. NMR Biomed (2007) 1.70
Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. NMR Biomed (2008) 1.70
Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer-poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med (2003) 1.68
Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells. Clin Cancer Res (2012) 1.67
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
High-throughput screening of chemical exchange saturation transfer MR contrast agents. Contrast Media Mol Imaging (2010) 1.59
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T. Neuroimage (2013) 1.58
Experimental measurement of extravascular parenchymal BOLD effects and tissue oxygen extraction fractions using multi-echo VASO fMRI at 1.5 and 3.0 T. Magn Reson Med (2005) 1.56
MRI-detectable pH nanosensors incorporated into hydrogels for in vivo sensing of transplanted-cell viability. Nat Mater (2013) 1.53
Superhigh-throughput needleless electrospinning using a rotary cone as spinneret. Small (2010) 1.52
Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52
On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med (2011) 1.51
Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn Reson Imaging (2008) 1.48
Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol (2002) 1.46
MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles. Magn Reson Med (2008) 1.46
Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T. Magn Reson Med (2011) 1.43
Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43
An account of the discrepancy between MRI and PET cerebral blood flow measures. A high-field MRI investigation. NMR Biomed (2006) 1.42
Flow territory mapping of the cerebral arteries with regional perfusion MRI. Stroke (2004) 1.41
Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc (2011) 1.41
Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging. Magn Reson Med (2005) 1.41
Reduced GABA concentration in attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2012) 1.35
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magn Reson Med (2006) 1.34
Three-dimensional diffusion tensor magnetic resonance microimaging of adult mouse brain and hippocampus. Neuroimage (2002) 1.33
In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28
Sickle cell disease: continuous arterial spin-labeling perfusion MR imaging in children. Radiology (2003) 1.26
Diffusion tensor MR imaging of the brain and white matter tractography. AJR Am J Roentgenol (2002) 1.24
Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24
Quantitative analysis of brain pathology based on MRI and brain atlases--applications for cerebral palsy. Neuroimage (2010) 1.24
Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid. J Magn Reson (2013) 1.23
Detrimental effects of BOLD signal in arterial spin labeling fMRI at high field strength. Magn Reson Med (2006) 1.21
Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21
Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7 T. Neuroimage (2012) 1.21
MRI reporter genes. J Nucl Med (2008) 1.19
Suppression of lipid artifacts in amide proton transfer imaging. Magn Reson Med (2005) 1.19
Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging. Magn Reson Med (2004) 1.17
A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients. Mol Imaging Biol (2009) 1.16
In vivo measurement of brain GABA concentrations by magnetic resonance spectroscopy in smelters occupationally exposed to manganese. Environ Health Perspect (2010) 1.16
In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn Reson Med (2011) 1.15
Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression. J Am Chem Soc (2013) 1.15
Determination of whole-brain oxygen extraction fractions by fast measurement of blood T(2) in the jugular vein. Magn Reson Med (2010) 1.13
Evidence of slow maturation of the superior longitudinal fasciculus in early childhood by diffusion tensor imaging. Neuroimage (2007) 1.13
Extending the loop design for two-channel microarray experiments. Genet Res (2006) 1.12
Magnetization transfer weighted imaging in the upper cervical spinal cord using cerebrospinal fluid as intersubject normalization reference (MTCSF imaging). Magn Reson Med (2005) 1.11